Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2 (NSAIDS II)

January 9, 2009 updated by: AstraZeneca
The current epidemiological study will be undertaken in GP's and specialized private doctors. In total, 85 general practitioners, orthopedics, rheumatologists and cardiologist will take part in the study. Data will be collected for 850 patients who visit their physician for medical conditions that require the use of acetylsalicylic acid and/or NSAIDS. The first 10 consecutive patients who visit their GP/orthopedic/rheumatologist/cardiologists and are currently receiving acetylsalicylic acid and/or NSAIDS will be included in the study.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Anticipated)

850

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Greece
      • Agrinio, Greece
        • Research Site
      • Alexandroupoli, Greece
        • Research Site
      • Argostoli, Greece
        • Research Site
      • Athens, Greece
        • Research Site
      • Chalkida, Greece
        • Research Site
      • Drama, Greece
        • Research Site
      • Heraklion, Greece
        • Research Site
      • Ioannina, Greece
        • Research Site
      • Kalamata, Greece
        • Research Site
      • Kallikratia, Greece
        • Research Site
      • Katerini, Greece
        • Research Site
      • Kiato, Greece
        • Research Site
      • Komotini, Greece
        • Research Site
      • Korinthos, Greece
        • Research Site
      • Kozani, Greece
        • Research Site
      • Lamia, Greece
        • Research Site
      • Larisa, Greece
        • Research Site
      • Patra, Greece
        • Research Site
      • Peireous, Greece
        • Research Site
      • Pirgos, Greece
        • Research Site
      • Preveza, Greece
        • Research Site
      • Rethimnon, Greece
        • Research Site
      • Serres, Greece
        • Research Site
      • Thessaloniki, Greece
        • Research Site
      • Tripoli, Greece
        • Research Site
      • Volos, Greece
        • Research Site
      • Xania, Greece
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Primary care

Description

Inclusion Criteria:

  • Acetylsalicylic acid/NSAIDS intake for at least 5 days of a week during the past month before the patient's visit to the clinician

Exclusion Criteria:

  • Patients who are not willing to sign of the Informed Consent Form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Primary care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Frequency (%) of patients in the Greek Primary Practice, presenting Upper GI Symptoms while receiving NSAIDS treatment with/without gastroprotective measures.
Time Frame: Single visit / once
Single visit / once

Secondary Outcome Measures

Outcome Measure
Time Frame
The nature of upper GI symptoms (Dyspepsia and GERD) experienced by patients receiving acetylsalicylic acid and / or NSAIDS treatment
Time Frame: single visit / once
single visit / once
To determine the main indications for acetylsalicylic acid and or NSAIDS prescription among GPs and specialized private doctors in Greece.
Time Frame: single visit / once
single visit / once

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Principal Investigator: Rokkas Theodoros, MD, Errikos Ntinan Hospital, Athens, Greece

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Study Completion (ACTUAL)

December 1, 2008

Study Registration Dates

First Submitted

June 3, 2008

First Submitted That Met QC Criteria

June 4, 2008

First Posted (ESTIMATE)

June 5, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

January 12, 2009

Last Update Submitted That Met QC Criteria

January 9, 2009

Last Verified

January 1, 2009

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-GGR-DUM-2008/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe